MY197992A - Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof - Google Patents

Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof

Info

Publication number
MY197992A
MY197992A MYPI2018703583A MYPI2018703583A MY197992A MY 197992 A MY197992 A MY 197992A MY PI2018703583 A MYPI2018703583 A MY PI2018703583A MY PI2018703583 A MYPI2018703583 A MY PI2018703583A MY 197992 A MY197992 A MY 197992A
Authority
MY
Malaysia
Prior art keywords
amorphizing agent
amorphizing
utilization
agent
amorphous composition
Prior art date
Application number
MYPI2018703583A
Inventor
Masuda Takaaki
Fujii Kahori
Kobayashi Hirokazu
Original Assignee
Nihon Nohyaku Co Ltd
Pola Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd, Pola Pharma Inc filed Critical Nihon Nohyaku Co Ltd
Publication of MY197992A publication Critical patent/MY197992A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention aims to provide an amorphization technique for a compound represented by General Formula (1) and/or a salt thereof. The present invention provides an amorphizing agent for a compound represented by General Formula (1) and/or a salt thereof, which amorphizing agent comprises one or more selected from the group consisting of water-soluble polymers and acids.
MYPI2018703583A 2016-03-31 2017-03-28 Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof MY197992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016071569 2016-03-31
PCT/JP2017/012578 WO2017170509A1 (en) 2016-03-31 2017-03-28 Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof

Publications (1)

Publication Number Publication Date
MY197992A true MY197992A (en) 2023-07-25

Family

ID=59964539

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018703583A MY197992A (en) 2016-03-31 2017-03-28 Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof

Country Status (8)

Country Link
JP (1) JP7021827B2 (en)
KR (1) KR102359641B1 (en)
CN (1) CN108883190B (en)
AU (1) AU2017244688B2 (en)
MY (1) MY197992A (en)
PH (1) PH12018502095A1 (en)
SG (1) SG11201808660UA (en)
WO (1) WO2017170509A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017181387A (en) * 2016-03-31 2017-10-05 株式会社ポーラファルマ Evaluation method of film formed by pharmaceutical composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3959205B2 (en) * 1999-08-04 2007-08-15 ポーラ化成工業株式会社 Surface-treated powder and external preparation for skin containing the same
ATE521349T1 (en) 2002-06-18 2011-09-15 Pola Pharma Inc ANTIFUNGAL MEDICAL COMPOSITIONS
JP2006312598A (en) 2005-05-09 2006-11-16 Pola Chem Ind Inc Medicinal composition
BRPI0621386B8 (en) * 2006-03-08 2021-07-13 Nihon Nihyaku Co Ltd pharmaceutical composition for external use
RU2415669C2 (en) * 2006-03-08 2011-04-10 Нихон Нохияку Ко., Лтд. Pharmaceutic composition for external application
JP4999412B2 (en) * 2006-09-20 2012-08-15 ポーラ化成工業株式会社 Fine particle powder and method for producing the same
WO2009031643A1 (en) * 2007-09-05 2009-03-12 Pola Pharma Inc. Antifungal composition
CN102387785B (en) * 2009-04-09 2017-08-25 宝丽制药股份有限公司 Antifungal medicine composition
AU2012295397A1 (en) * 2011-08-16 2014-02-20 Merck Sharp & Dohme Corp. Use of inorganic matrix and organic polymer combinations for preparing stable amorphous dispersions
JP5662495B2 (en) * 2013-02-08 2015-01-28 株式会社ポーラファルマ Pharmaceutical composition in solubilizer form
JP6503626B2 (en) * 2013-03-28 2019-04-24 大正製薬株式会社 Pharmaceutical composition
JP5587488B1 (en) * 2013-12-12 2014-09-10 株式会社ポーラファルマ Evaluation method and index substance of preparation containing luliconazole

Also Published As

Publication number Publication date
JP2017186317A (en) 2017-10-12
CN108883190A (en) 2018-11-23
SG11201808660UA (en) 2018-11-29
AU2017244688B2 (en) 2022-11-10
KR20180126058A (en) 2018-11-26
WO2017170509A1 (en) 2017-10-05
JP7021827B2 (en) 2022-02-17
KR102359641B1 (en) 2022-02-08
CN108883190B (en) 2022-07-01
AU2017244688A1 (en) 2018-11-22
PH12018502095A1 (en) 2019-07-15

Similar Documents

Publication Publication Date Title
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
SG11201804121RA (en) Novel biphenyl compound or salt thereof
MX2020005873A (en) 6-azaindole compounds.
MX2020006168A (en) 4-azaindole compounds.
MX2018005292A (en) Acc inhibitors and uses thereof.
MX2021010885A (en) Pyrimidinyloxy benzene derivatives as herbicides.
MX2018006288A (en) Ester acc inhibitors and uses thereof.
MX2020006014A (en) Diazaindole compounds.
WO2018006074A3 (en) Compounds and methods for modulating rna function
WO2016044463A3 (en) Mk2 inhibitors and uses thereof
MX2019014104A (en) Novel biphenyl compound or salt thereof.
MX2022010755A (en) Kinase inhibitors and uses thereof.
PE20170439A1 (en) DERIVED FROM BIS (ARIL) CATECOL AS HERBICIDES
WO2017160116A3 (en) Novel compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
MY177933A (en) Herbicidal composition comprising quizalofop-p
MX2019004294A (en) 4-substituted phenylamine derivatives and their use to protect crops by fighting undesired phytopathogenic micoorganisms.
EA201990304A1 (en) PLANT CONTROL METHOD
WO2018160879A3 (en) Macromolecular corrosion (mcin) inhibitors: structures, methods of making and using the same
MX2020006434A (en) Novel mtor inhibitor compounds.
MX2020006370A (en) Pyrazolopyridine-diamides, their use as insecticide and processes for preparing the same.
MX2018001517A (en) Substituted guanidine derivative.
MX2015016332A (en) Pyrrolotriazines as alk inhibitors.
MX2017001064A (en) Pyridones as herbicides.
MY182814A (en) Flux activator agent, flux, and solder
MX2019004293A (en) 4-amino substituted phenylamidine derivatives and their use to protect crops by fighting undesired phytopathogenic micoorganisms.